AzTrials
AzTrials

Brain ConcussionNCT05859815

The Role of Mechanical Diagnosis and Therapy in the Management of Concussion

An observational study of Brain Concussion and Mild Traumatic Brain Injury, run by State University of New York at Buffalo at 2 sites in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The purpose of this study is to examine the role of a Mechanical Diagnosis and Therapy (MDT) examination in identifying participants diagnosed with concussion who display a directional preference compared to who don't display a directional preference. Read more about this study

Who is it for?
Ages 13 to 65 years
Conditions the study is for
Brain Concussion, Mild Traumatic Brain Injury
What is being tested?
Physical Therapy
How many people
13 participants
Where
2 sitesUnited States
Study dates
20 Jul 2023to 10 Feb 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 65 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: The study population will consist of patients who have been diagnosed with a concussion and referred for outpatient physical therapy services.

Who may be able to join

  • Age = 13 - 65
  • Complaints of neck pain, headache, or dizziness associated with a diagnosis of concussion or mild TBI
  • Ability to read/write English
  • Referral from physician

Who cannot join

  • Age less than 13 or greater than 65
  • Cause of symptoms is result of a work-related accident or motor vehicle accident
  • Receiving concurrent treatment from a chiropractor or massage therapist
  • Glasgow Coma Scale less than 12
  • Lesion on head CT/MRI
  • Focal neurological deficits associated with serious spinal pathology (fracture, infection, tumor, vertebrobasilar insufficiency)
Show all 9Show fewer
  • Inability to or unwilling to exercise as part of usual PT care
  • Unable to read/write English
  • History of osteopenia/osteoporosis or cancer

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Summit Healthplex Physcial Therapy/Niagara Falls Memorial Medical Center

    Niagara Falls, New York, 14304

  • Goodlife Physical Therapy

    Orland Park, Illinois, 60467

Other trials in United States

About this study

Official title: The Role of Mechanical Diagnosis and Therapy in the Classification and Management of Concussion

The purpose of this study is to examine the role of a Mechanical Diagnosis and Therapy (MDT) examination in identifying participants diagnosed with concussion who display a directional preference compared to who don't display a directional preference.

Read the detailed description

Directional preference describes the clinical phenomenon where a specific direction of repeated movement and / or sustained position results in a clinically relevant improvement in symptoms. This improvement is usually accompanied by an improvement in function or mechanics or both. Its presence and relevance is determined over 2-3 visits. This study aims to identify the proportion of participants with concussion who present with a directional preference during the course of physical therapy. A secondary aim of this study is to investigate whether directional preference is associated with the eventual patient related outcomes following care.

Being tested
Physical Therapy
Keywords
Mechanical Diagnosis and Therapy, Directional Preference, Repeated Movements
Medical subject headings
Brain Concussion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physical TherapyBehavioural

    As part of their normal care, participants will receive any combination of the following interventions to address their specific needs identified during the initial evaluation: cervical spine repeated movements (active range of motion), cervical spine stabilization exercise, aerobic exercise, motor control training, oculomotor/vestibular rehabilitation, stretching, soft-tissue mobilization, joint mobilization, and postural re-education activities.

Study groups in NCT05859815
Study groupRoleWhat they receive
Directional preference responderThis group is comprised of participants who responded to repeated movements in a direction (e.g., neck flexion) that significantly improved their symptoms and/or their ability to move their head/neck.
Receives: Behavioral: Physical Therapy
Directional preference non-responderThis group is comprised of participants who did not respond to repeated movements in any specific direction that significantly improved their symptoms and/or their ability to move their head/neck.
Receives: Behavioral: Physical Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Directional preference classification

    Outcome represents the patient's directional preference at the time of discharge from care. Patients will be classified as directional preference responders or non-responders.

    Measured: Through study completion, up to 1 year.

Secondary outcomes (3)
  1. Post-Concussion Symptom Scale

    The PCSS is a patient self-reported outcome measure that measures the amount of interference associated with a concussion across four domains: physical, cognitive, emotion, and sleep. The measure consists of 22 questions that relate to post-concussive symptoms. The measure uses a 7-point Likert scale, where 0 = no symptoms and 6 = severe symptoms. The greatest possible score is 132 and the lowest score is 0. Higher scores indicate higher severity of post-concussive symptoms.

    Measured: Through study completion, up to 1 year.

  2. Neck Disability Index

    The NDI is a patient self-reported outcome measure that measures the amounts of pain interference and self-reported disability related to neck pain. The measure consists of ten questions in the following domains: pain intensity, personal care, lifting, reading, sleeping, work, recreation, reading, concentration, and headaches. Each item is rated on a 0 to 5 scale, where 0 = no disability and 5 = complete disability. The highest possible raw score equals 50 points, the lowest possible score equals 0. The raw scores can also be converted to a percentage from 0 to 100%. Higher scores indicate higher levels of self-reported disability.

    Measured: Through study completion, up to 1 year.

  3. Dizziness Handicap Inventory

    The DHI is a patient self-reported outcome measure that measures the impact of dizziness on daily life. The DHI consists of 25 items measuring the impact of dizziness across three domains: functional (9 questions,= 36 points), emotional (9 questions = 36 points), and physical (7 questions = 28 points). Each item is rated on a 3 point scale (yes = 4, sometimes = 2, no = 0). Item scores are summed, with a possible total of 100 points. The best possible score is a 0. Higher scores indicate greater perceived handicap due to dizziness.

    Measured: Through study completion, up to 1 year.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 May 2023
  2. Study start20 Jul 2023
  3. Primary completion10 Feb 2026
  4. Study completion10 Feb 2026

Why it stopped: Study was terminated due to lack of referral sources and limited participant enrollment.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
13 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05859815
Sponsor's protocol ID
STUDY00006666
Status last verified
Feb 2026
First submitted
22 Mar 2023
Last updated
13 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared with other researchers.

Questions about this trial

What is this clinical trial studying?

An observational study of Brain Concussion and Mild Traumatic Brain Injury, run by State University of New York at Buffalo at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 13 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Study was terminated due to lack of referral sources and limited participant enrollment.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Directional preference classification (time frame: Through study completion, up to 1 year.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in